Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Everolimus plus octreotide long-acting repeatable for the... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
0
Authors
Marianne Pavel
•
Marianne Pavel
13 more
•
James Yao
Published
December 1, 2011
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Cancer Oncology
Epidemiology
Pathology
Internal Medicine
Urology
Surgery
Gastroenterology
Medicine
Cancer Oncology
Epidemiology
Pathology
Internal Medicine
Show all topics
DOI
10.1016/s0140-6736(11)61742-x
